FBTIX
Fidelity Advisor Biotechnology Fund
1W: -1.9%
1M: -8.1%
3M: +0.1%
YTD: +23.7%
1Y: +37.0%
3Y: +109.0%
5Y: +76.6%
$50.65
-0.01 (-0.02%)
Weekly Expected Move ±2.6%
$48
$49
$51
$52
$53
ETF-Level Metrics
AUM$2.2B
Holdings76
Top 10 Wt47.0%
Beta0.63
% Profitable9%
Coverage95%
Portfolio Valuation
P/E68.5
P/B31.8
P/S7.2
EV/EBITDA28.2
P/FCF23.3
PEG-6.56
Profitability & Returns
Gross Margin75.3%
Net Margin7.3%
ROE32.3%
ROA3.5%
ROIC16.9%
Div Yield0.61%
Leverage & Liquidity
Debt/Equity4.51
Debt/Assets0.49
Net Debt/EBITDA2.9x
Interest Cov3.8x
Current Ratio1.06
Quick Ratio0.91
Growth (YoY)
Revenue+32.4%
Net Income+15.2%
EPS+28.7%
FCF+13.2%
EBITDA+14.4%
Rev CAGR 3Y+57.2%
Quality Scores
Piotroski F4.3
Altman Z26.57
IS Quality57.9
IS Overall52.8
IS Value34.0
Median P/E-6.3
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 76 | 96.3% | -20.9 |
| Other | 40 | 3.9% | — |
Smart Money Overlap
1 holdings with signals| Symbol | Company | Weight % | Signals | Badge | Insider Buys | Congress | Since Signal |
|---|---|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals, Inc. | 2.25% | 3 | Bullish | 1 | 0 | +99.5% |
Showing 50 of 116 holdings
· Page 1 of 3
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVie Inc | ABBV | 14.71% | $323.7M | 1,229,563 | 74.0 | $464.3B | Healthcare |
| 2 | Gilead Sciences Inc | GILD | 5.70% | $125.5M | 829,305 | -55.7 | $179.5B | Healthcare |
| 3 | Spyre Therapeutics Inc | SYRE | 3.83% | $84.3M | 995,077 | -47.8 | $8.1B | Healthcare |
| 4 | Alnylam Pharmaceuticals Inc | ALNY | 3.62% | $79.6M | 313,199 | 36.0 | $29.4B | Healthcare |
| 5 | Dianthus Therapeutics Inc | DNTH | 3.55% | $78.1M | 895,574 | -678.5 | $4.9B | Healthcare |
| 6 | Cogent Biosciences Inc | COGT | 3.25% | $71.4M | 2,256,142 | -13.4 | $5.3B | Healthcare |
| 7 | Oruka Therapeutics Inc | ORKA | 3.23% | $71.2M | 866,283 | -34.2 | $5.1B | Healthcare |
| 8 | Insmed Inc | INSM | 3.05% | $67.1M | 580,105 | -27.0 | $24.1B | Healthcare |
| 9 | Revolution Medicines Inc | RVMD | 3.00% | $66.0M | 323,005 | -23.3 | $43.9B | Healthcare |
| 10 | Argenx SE ADR | ARGX | 3.00% | $65.9M | 67,907 | 33.3 | $57.2B | Healthcare |
| 11 | Ascendis Pharma A/S | ASND | 2.98% | $65.7M | 287,923 | 16.7 | $14.2B | Healthcare |
| 12 | Biogen Inc | BIIB | 2.71% | $59.7M | 262,860 | 38.7 | $32.5B | Healthcare |
| 13 | MBX Biosciences Inc | MBX | 2.45% | $53.9M | 933,409 | -24.4 | $2.8B | Healthcare |
| 14 | Amgen Inc | AMGN | 2.37% | $52.0M | 122,831 | 24.8 | $217.5B | Healthcare |
| 15 | Amylyx Pharmaceuticals Inc | AMLX | 2.25% | $49.4M | 1,687,783 | -19.7 | $3.1B | Healthcare |
| 16 | Vaxcyte Inc | PCVX | 1.97% | $43.3M | 764,627 | -7.4 | $8.2B | Healthcare |
| 17 | Moderna Inc | MRNA | 1.60% | $35.1M | 172,656 | -23.8 | $75.4B | Healthcare |
| 18 | Relay Therapeutics Inc | RLAY | 1.58% | $34.8M | 1,898,076 | -12.1 | $4.2B | Healthcare |
| 19 | Viridian Therapeutics Inc | VRDN | 1.53% | $33.7M | 1,686,633 | -5.5 | $2.2B | Healthcare |
| 20 | Natera Inc | NTRA | 1.43% | $31.4M | 75,706 | -301.7 | $58.8B | Healthcare |
| 21 | Kiniksa Pharmaceuticals International Plc Class A | KNSA | 1.41% | $31.0M | 409,935 | 70.8 | $5.8B | Healthcare |
| 22 | Vertex Pharmaceuticals Inc | VRTX | 1.39% | $30.5M | 57,879 | 29.1 | $128.1B | Healthcare |
| 23 | Enliven Therapeutics Inc | ELVN | 1.25% | $27.5M | 590,840 | -28.6 | $3.4B | Healthcare |
| 24 | Alumis Inc | ALMS | 1.22% | $26.7M | 3,667,850 | -1.8 | $846M | Healthcare |
| 25 | Roivant Sciences Ltd | ROIV | 1.20% | $26.3M | 721,586 | -94.0 | $25.8B | Healthcare |
| 26 | Structure Therapeutics Inc ADR | GPCR | 1.15% | $25.4M | 775,782 | -9.1 | $1.6B | Healthcare |
| 27 | Kymera Therapeutics Inc | KYMR | 1.09% | $24.0M | 216,793 | -33.0 | $8.8B | Healthcare |
| 28 | Praxis Precision Medicines Inc | PRAX | 1.04% | $22.8M | 81,285 | -22.8 | $8.2B | Healthcare |
| 29 | Xenon Pharmaceuticals Inc | XENE | 0.97% | $21.4M | 575,820 | -8.0 | $3.7B | Healthcare |
| 30 | Celldex Therapeutics Inc | CLDX | 0.89% | $19.5M | 616,312 | -7.3 | $2.1B | Healthcare |
| 31 | Parabilis Medicines Inc Private | — | 0.82% | $18.0M | — | — | — | — |
| 32 | Regeneron Pharmaceuticals Inc | REGN | 0.78% | $17.2M | 22,863 | 17.6 | $75.7B | Healthcare |
| 33 | Zenas Biopharma Inc | ZBIO | 0.70% | $15.5M | 577,721 | -2.9 | $1.8B | Healthcare |
| 34 | First Tracks Biotherapeutics Inc | TRAX | 0.68% | $15.0M | 417,572 | — | $1.2B | Healthcare |
| 35 | Mirum Pharmaceuticals Inc | MIRM | 0.65% | $14.3M | 163,512 | -5.7 | $5.1B | Healthcare |
| 36 | Viking Therapeutics Inc | VKTX | 0.65% | $14.3M | 449,196 | -6.4 | $3.5B | Healthcare |
| 37 | Jade Biosciences Inc | JBIO | 0.63% | $13.8M | 973,114 | -5.1 | $859M | Healthcare |
| 38 | Newamsterdam Pharma Co NV | NAMS | 0.57% | $12.4M | 522,886 | -10.6 | $2.7B | Healthcare |
| 39 | Dyne Therapeutics Inc | DYN | 0.55% | $12.1M | 748,721 | -4.6 | $2.8B | Healthcare |
| 40 | Climb Bio Inc | CLYM | 0.54% | $11.9M | 1,031,057 | -13.2 | $626M | Healthcare |
| 41 | Arcus Biosciences Inc | RCUS | 0.54% | $11.8M | 459,283 | -6.2 | $3.1B | Healthcare |
| 42 | Avalo Therapeutics Inc | AVTX | 0.53% | $11.7M | 749,328 | -3.2 | $788M | Healthcare |
| 43 | Tyra Biosciences Inc | TYRA | 0.51% | $11.3M | 513,735 | -8.5 | $1.2B | Healthcare |
| 44 | CG oncology Inc | CGON | 0.51% | $11.2M | 159,198 | -25.0 | $5.9B | Healthcare |
| 45 | uniQure NV | 0EE0.L | 0.44% | $9.8M | 395,110 | -5.8 | $1.4B | Healthcare |
| 46 | Stoke Therapeutics Inc | STOK | 0.42% | $9.2M | 354,282 | -7.6 | $1.7B | Healthcare |
| 47 | Olema Pharmaceuticals Inc | OLMA | 0.41% | $8.9M | 1,042,030 | -3.9 | $718M | Healthcare |
| 48 | Hemab Therapeutics Holdings Inc | COAG | 0.40% | $8.9M | 272,319 | — | $1.5B | Healthcare |
| 49 | Damora Therapeutics Inc | DMRA | 0.39% | $8.6M | 418,351 | — | $1.3B | Healthcare |
| 50 | Fidelity Cash Central Fund Cash | — | 0.39% | $8.5M | — | — | — | — |